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Abstract: In preeclampsia, alterations in
renal function, electrolyte and water
metabolism are common findings. Recent
studies have suggested that preeclampsia is
associated with hypocalciuria. A total of 59
women were included in the present study,
15 of whom were nonpregnant (NP) healthy
women, 20 normotensive pregnant women
(NTP), and 24 pregnant women with severe
preeclampsia (PEP). We compared the three
groups in terms of calcium and phosphate
excretion, and some parameters of renal
function such as serum urea, creatinine and
creatinine clearance. Urinary calcium and
phosphate levels in the PEP group were
significantly lower than in the NP group (p<
0.001 and p< 0.01, respectively) and NTP
group (p< 0.001 and p< 0.01, respectively).
The serum urea levels were higher in the PEP
group than in the NP and NTP (p< 0.001)
groups. The same pattern of increase in the
PEP group was valid for serum creatinine
concentrations as compared with the NP (p<

Introduction
Preeclampsia is a pregnancy-specific disease
manifested by hypertension, coagulopathy, and impaired
tissue perfusion. Its etiology remains unclear, and it is
possible that the rise in blood pressure is a manifestation
of more than one pathophysiological condition (1-4). One
of these conditions is related to abnormal renal function
(5-8) and probably decreased urinary calcium excretion
(9-12).
Calcium and phosphate metabolism during normal
pregnancy is characterized by minor changes in the serum
levels of calcium and phosphate; however, urinary calcium
and phosphate excretion increases (8,13). While urinary
calcium values in nonpregnant women are about 100 250 mg/day, in pregnant women they range between
350 - 620 mg/day (8,14). Alongside the many studies
reporting hypocalciuria in preeclampsia, there are others
that have found no such correlation (15).

0.01) and NTP (p< 0.001) levels. The
glomerular filtration rate measured by
creatinine clearance was lower in
preeclamptic women than in normotensive
pregnant women (p< 0.01). Patients with
preeclampsia had significantly lower (p<
0.001) excretion of calcium than the NP and
NTP groups (p< 0.001). Likewise, the
phosphate levels were lower in women with
preeclampsia than in the NP and NTP groups
(p< 0.01). There was no correlation between
parameters of renal function and calcium or
phosphate excretion.
Hypocalciuria and hypophosphateuria were
found to be important features of severe
preeclampsia and probably indirectly are
related to the altered renal function seen in
toxemia of pregnancy.
Key Words: Preeclampsia; calcium excretion;
phosphate excretion; renal function

It is unclear whether the decrease of calcium is due to
disordered renal function or is a compensatory
mechanism in the pathogenesis of preeclampsia. The
purpose of this study was to determine whether the
calcium and phosphate excretion is lower in patients with
preeclampsia, and what relation there is, if any, between
calcium/phosphate excretion and the changed renal
function seen in toxemia of pregnancy.
Material and Methods
The cases were divided into three groups: 15
nonpregnant (NP) healthy women (Control I), 20
normotensive pregnant (NTP) women with no disease
(Control II), and 24 pregnant women with severe
preeclampsia (PEP) (Study). Severe preeclampsia was
defined as a blood pressure of ≥160/110 mmHg after 30
minutes of rest on two separate readings at least 6 hours
apart with proteinuria (more than 300mg/day), and
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edema. Liver enzyme levels of preeclamptic pregnant
women were found to be in normal ranges. Preeclamptic
and normotensive pregnant women were nullipara, and
the gestational age was 33.25 ± 4.20 and 31.90 ± 5.89
weeks, respectively (Table1). Nonpregnant healthy
women were 25-32 years of age. All women (Control I,
II and Study groups) did not take any medication for at
least 10 days prior the sample collection. Nonpregnant
women were not on oral contraceptives and were in the
follicular phase of the menstrual cycle at the time of
sampling. Patients who had a history of hypertension
before the 20th week of pregnancy, diabetes mellitus, or
any renal disease were excluded from the study. All
participants were on a free range diet. Twenty-four urine
collections were taken from Control I, Control II and
Study groups. Venous blood was obtained after overnight
fasting at 1000 hours with each 24-hour urine collection,
and centrifuged at 2000 g to remove the serum. Serum
and urinary creatinine and urea levels were determined by
the Jaffe and Kowarski methods, respectively. Creatinine
clearance was then calculated. Urinary calcium and
phosphate were determined by the Kramer-Tisdall and
phosphomolibdic acid methods, respectively. Data are
given as mean ± standard deviation. Student’s t test and
simple correlation analysis were used as statistical
methods to test the results.

(0.71 ± 0.18 mg/dl) (p< 0.01) and NTP group (0.69 ±
0.06 mg/dl) (p< 0.001). No significant difference was
found between the urea and creatinine values of NTP
women and those of NP ones. The creatinine clearance of
PEP women (104.38 ± 29.63 ml/min) was lower than
that of NTP women (126.20 ± 15.14 ml/min) (p< 0.01).
However, there was no difference in comparison between
the PEP and NP (113.04 ± 14.98 ml/min) groups. The
creatinine clearance of normotensive pregnant women
was higher than that of nonpregnant ones (p< 0.05).
Table 2.

Renal function values in nonpregnant healthy (NP) women,
normotensive pregnant women (NTP) and preeclamptic
pregnant women (PEP)
Serum Urea

Serum Creatinine

Creatinine

(mg/dl)

(mg/dl)

Clearance (ml/min)

NP (n = 15)

19.33±1.44

0.71±0.18

113.04±14.98

NTP(n = 20)

19.10±1.51

0.69±0.06

126.20±15.14

(mg/dl)

+

PEP(n = 24)

+

NS

23.08±3.11
*
p<0.001
a

+

NS

0.88±0.17

104.38±29.63

*

a

p<0.01
a
p<0.001

p<0.001

p<0.05

p<0.01

* Between PEP and NP
a Between PEP and NTP
+ Between NTP and NP

Results
Table 1 presents the gestational age and systolic and
diastolic blood pressure values of normotensive and
preeclamptic pregnant women.
Table 1.

Clinical findings of normotensive pregnants (NTP) and
preeclamptic pregnants (PEP)
Gestationa

Systolic Blood

Diastolic Blood

Age(week)

Pressure(mmHg)

Pressure(mmHg)

NTP(n = 20)

31.9 ± 5.89

115 ± 10.51

74 ± 6.8

PEP(n = 24)

33.25 ± 4.20

164.58 ± 20.79

104.79 ± 12.63

NS

p < 0.001

p < 0.001

P

Table 2 lists the renal function values in NP healthy,
NTP and PEP women. Serum urea concentrations of the
PEP group (23.08 ± 3.11 mg/dl) were significantly
higher than those of the NP women (19.33 ± 1.44
mg/dl) and NTP ones (19.10 ± 1.51 mg/dl) (p< 0.001).
The same pattern was seen in serum creatinine
concentrations, which were significantly higher in the
Study group (0.88 ± 0.17 mg/dl) than in the NP group
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Patients with preeclampsia had significantly lower
excretion of calcium (92.14 ± 40.87 mg/l) than the NP
(152.53 ± 25.60 mg/l) and NTP (171.80 ± 60.01 mg/l)
groups (p< 0.001). Likewise, the phosphate levels (0.43
± 0.38 g/l) were lower in women with preeclampsia than
in the NP (0.80 ± 0.40 g/l) and NTP (0.76 ± 0.34 g/l)
groups (p< 0.01).
There was no correlation between urinary calcium,
phosphate and parameters of renal function.
Table 3.

Urinary calcium and phosphate in nonpregnant healthy
(NP), normotensive pregnant women (NTP) and
preeclamptic pregnant women (PEP)
Urine Ca (mg/l)

Urine P (g/l)

NP (n = 15)

152.53 ± 25.60

0.80 ± 0.40

NTP(n = 20)

178.8 ± 60.01

0.76± 0.34

PEP(n = 24)

* Between PEP and NP
a Between PEP and NTP
+ Between NTP and NP

+NS

+NS

92.14± 40.87

0.43± 0.38

*

p<0.001

*

p<0.01

a

p<0.001

a

p<0.01

P. VURAL, C. AKGUL, M. CANBAZ

Discussion
Preeclampsia can cause changes in virtually all organ
systems, especially the cardiovascular, renal,
hematological and immunological systems. The reason for
these changes is unknown, but it is believed that they may
be associated with an inadequate vasoactive prostaglandin
synthesis (16-18), which can cause disorders of
uteroplacental circulation (19), and renal tissue (5) and
renal perfusion deffects (20). In association with these
alterations renal blood flow and glomerular filtration
rates decrease with the development of toxemia (20),
which results in the decrease of urea and creatinine
excretion (7). Similar to the reports of many
investigators, in our study we also found serum urea and
creatinine levels to be higher in preeclamptic pregnant
women than in nonpregnant healthy women and
normotensive pregnant women, while creatinine
clearance values in preeclampsia were lower than in
normotensive pregnant women.
Renal excretion of calcium and phosphate increases
during pregnancy (8). Excretion usually increases during
each trimester, with maximum levels reached during the
third trimester. Proteinuria and alterations of phosphate
and most notably calcium excretion are common findings
of hypertension and some renal disorders in general.
There is a decrease in urinary calcium levels in
preeclampsia (9-12). Our findings in preeclampsia
confirm the results of Sanchez-Ramos, Yoshida and
Taufield (9-11). The reason for hypercalciuria in
pregnancy is probably the increased glomerular filtration
rate (11). Pedersen et al. reported that the fractional

excretion of calcium in preeclamptic pregnant women was
lower in the third trimester than it was in normotensive
pregnant women (21). Because parathyroid hormone and
calcitonin levels were not altered in the patients with
preeclampsia, it was concluded that the differences in
calcium metabolism were not related to alterations in the
secretion of these hormones. Decreased renal filtration
rate and increased tubular reabsorption of calcium and
phosphate may result in hypocalciuria, and
hypophosphateuria in toxemia. This may be a
compensatory mechanism. Decreased calcium excretion
may result in a slight but significant increase in serum
levels, so that phospholipase A2 is activated to stimulate
impaired prostaglandin synthesis. It is reported that
adaily supplement of 2000 mg calcium had significant
results in lowering the incidence of toxemia (22). In
addition, nonpregnant women with a calcium intake of at
least 1000mg/day had a 20% lower risk of hypertension
than women with an intake of less than 400 mg/day
during four years of follow-up (23). These facts support
our hypothesis.
Lower calcium excretion may result from dietary
variation. All participants in our study were on a free
range diet. Because we did not advise any of our patient
to alter their diets, however, we believe it is unlikely that
dietary calcium intake played an important role in our
findings.
As a conclusion, hypocalciuria and hypophosphateuria
are important features of severe preeclampsia and
probably are indirectly related to the altered renal
function seen in toxemia of pregnancy.
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